The mobilization of endothelial progenitor cells (EPCs) into circulation from bone marrow is well known to be present in several clinical settings, including acute coronary syndrome, heart failure, diabetes and peripheral vascular disease. The aim of this review was to explore the current literature focusing on the great opportunity that EPCs can have in terms of regenerative medicine.
Endothelial progenitor cells: An appraisal of relevant data from bench to bedside
Morrone D.
;Felice F.
;De Martino A.;Scatena C.;Naccarato A. G.;Di Stefano R.;Dal Monte M.;Pini S.;
2021-01-01
Abstract
The mobilization of endothelial progenitor cells (EPCs) into circulation from bone marrow is well known to be present in several clinical settings, including acute coronary syndrome, heart failure, diabetes and peripheral vascular disease. The aim of this review was to explore the current literature focusing on the great opportunity that EPCs can have in terms of regenerative medicine.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2021 - IJMS.pdf
accesso aperto
Tipologia:
Versione finale editoriale
Licenza:
Creative commons
Dimensione
651.24 kB
Formato
Adobe PDF
|
651.24 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
